Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism

[1]  Yanli Zeng,et al.  Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis , 2022, Drug delivery.

[2]  P. Song,et al.  Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice , 2022, Theranostics.

[3]  Fengping An,et al.  Changes in volatile flavor of yak meat during oxidation based on multi-omics. , 2021, Food chemistry.

[4]  Qingfeng Li,et al.  Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment , 2021, Gut.

[5]  R. Xu,et al.  Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial , 2021, Hepatology International.

[6]  Hong Tang,et al.  Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases , 2021, Journal of Gastroenterology.

[7]  S. Terai,et al.  The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future , 2020, Clinical and molecular hepatology.

[8]  Qingxi Chen,et al.  Anoectochilus roxburghii polysaccharide prevents carbon tetrachloride-induced liver injury in mice by metabolomic analysis. , 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  F. Prósper,et al.  Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis , 2020, Gut.

[10]  Ling Lu,et al.  Mesenchymal stem cell therapy for liver fibrosis/cirrhosis , 2020, Annals of translational medicine.

[11]  G. Ding,et al.  Exosomal miR‐103‐3p from LPS‐activated THP‐1 macrophage contributes to the activation of hepatic stellate cells , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  D. Song,et al.  Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[13]  B. Bartosch,et al.  Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis , 2019, Cells.

[14]  Ling-ling Wei,et al.  The Effect of Vascular Endothelial Growth Factor on Bone Marrow Mesenchymal Stem Cell Engraftment in Rat Fibrotic Liver upon Transplantation , 2019, Stem cells international.

[15]  David R. Jones,et al.  Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis , 2019, Nature Cell Biology.

[16]  P. Morel,et al.  Extracellular vesicles: Future diagnostic and therapeutic tools for liver disease and regeneration , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[17]  Runping Liu,et al.  Cholangiocyte‐Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis , 2019, Hepatology.

[18]  Y. Lei,et al.  MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway. , 2019, Clinics and research in hepatology and gastroenterology.

[19]  S. Terai,et al.  Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration , 2019, Inflammation and Regeneration.

[20]  D. Sabry,et al.  The Effect of Mesenchymal Stem Cells Derived Microvesicles on the Treatment of Experimental CCL4 Induced Liver Fibrosis in Rats , 2019, International journal of stem cells.

[21]  Yimin Wang,et al.  Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway , 2019, Stem Cell Research & Therapy.

[22]  Hong Wang,et al.  Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages. , 2019, Biochemical and biophysical research communications.

[23]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[24]  D. Brenner,et al.  Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis , 2018, Hepatology communications.

[25]  W. Syn,et al.  Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis , 2018, Front. Cell Dev. Biol..

[26]  Yanning Liu,et al.  AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages , 2018, EBioMedicine.

[27]  Yin‐peng Jin,et al.  Extracellular Vesicles Secreted by Human Adipose-derived Stem Cells (hASCs) Improve Survival Rate of Rats with Acute Liver Failure by Releasing lncRNA H19 , 2018, EBioMedicine.

[28]  Ruogang Zhao,et al.  Fibrotic microtissue array to predict anti-fibrosis drug efficacy , 2018, Nature Communications.

[29]  J. Wolfram,et al.  Extracellular vesicle therapeutics for liver disease , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Youwen Tan,et al.  Human Umbilical Cord MSC-Derived Exosomes Suppress the Development of CCl4-Induced Liver Injury through Antioxidant Effect , 2018, Stem cells international.

[31]  J. Ladero,et al.  Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[32]  R. Compans,et al.  Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses , 2018, Nature Communications.

[33]  G. Mazza,et al.  Engineering in vitro models of hepatofibrogenesis , 2017, Advanced drug delivery reviews.

[34]  N. Arsenijević,et al.  Mesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potential , 2017, BioFactors.

[35]  Yanning Liu,et al.  Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases , 2017, Experimental &Molecular Medicine.

[36]  Yanning Liu,et al.  MiR‐122 modification enhances the therapeutic efficacy of adipose tissue‐derived mesenchymal stem cells against liver fibrosis , 2017, Journal of cellular and molecular medicine.

[37]  Lungen Lu,et al.  Exosomes derived from miR‐181‐5p‐modified adipose‐derived mesenchymal stem cells prevent liver fibrosis via autophagy activation , 2017, Journal of cellular and molecular medicine.

[38]  Myeong Jun Song,et al.  Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice. , 2017, Gastroenterology.

[39]  M. Merchant,et al.  The hepatic “matrisome” responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice , 2017, Hepatology.

[40]  C. Kahn,et al.  Adipose-Derived Circulating miRNAs Regulate Gene Expression in Other Tissues , 2017, Nature.

[41]  H. Yasuda,et al.  Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells , 2016, Scientific Reports.

[42]  G. Gores,et al.  Extracellular vesicles in liver pathobiology: Small particles with big impact , 2016, Hepatology.

[43]  Fang Wu,et al.  Serum metabonomics study of the hepatoprotective effect of Corydalis saxicola Bunting on carbon tetrachloride-induced acute hepatotoxicity in rats by (1)H NMR analysis. , 2016, Journal of pharmaceutical and biomedical analysis.

[44]  W. Cui,et al.  Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination , 2016, Development.

[45]  T. Hankemeier,et al.  Metabolic characterization of the natural progression of chronic hepatitis B , 2016, Genome Medicine.

[46]  M. Birnbaum,et al.  Akt‐mediated foxo1 inhibition is required for liver regeneration , 2016, Hepatology.

[47]  X. Qin,et al.  (1)H NMR based metabolomic profiling revealed doxorubicin-induced systematic alterations in a rat model. , 2016, Journal of pharmaceutical and biomedical analysis.

[48]  S. Ng,et al.  Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features , 2015, Stem cells international.

[49]  Da-Zhi Wang,et al.  Pi3kcb Links Hippo-YAP and PI3K-AKT Signaling Pathways to Promote Cardiomyocyte Proliferation and Survival , 2015, Circulation research.

[50]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[51]  S. Proctor,et al.  Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. , 2014, The Journal of nutrition.

[52]  B. Yu,et al.  Exosomes Derived from Mesenchymal Stem Cells , 2014, International journal of molecular sciences.

[53]  M. Seifert,et al.  Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. , 2013, Transplant immunology.

[54]  Joy X Jiang,et al.  Liver Injury and the Activation of the Hepatic Myofibroblasts , 2013, Current Pathobiology Reports.

[55]  Wei Zhang,et al.  Studies of single-walled carbon nanotubes-induced hepatotoxicity by NMR-based metabonomics of rat blood plasma and liver extracts , 2013, Nanoscale Research Letters.

[56]  B. Wang,et al.  Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. , 2013, Stem Cells and Development.

[57]  G. Camussi,et al.  Role of stem-cell-derived microvesicles in the paracrine action of stem cells. , 2013, Biochemical Society transactions.

[58]  S. Zeisel,et al.  Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression , 2012, Current opinion in gastroenterology.

[59]  R. Urtasun,et al.  Osteopontin, an oxidant stress sensitive cytokine, up‐regulates collagen‐I via integrin αVβ3 engagement and PI3K/pAkt/NFκB signaling , 2012, Hepatology.

[60]  F. Bellanti,et al.  Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet , 2011, PloS one.

[61]  D. Raptis,et al.  The model for end‐stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[62]  M. Matin,et al.  Comparative Analysis of Chemokine Receptor's Expression in Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue , 2011, Journal of Molecular Neuroscience.

[63]  J. Lindquist,et al.  Inhibition of phosphatidylinositol 3‐kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis , 2009, Hepatology.

[64]  C. Palmeira,et al.  Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. , 2008, Mitochondrion.

[65]  A. Buchman,et al.  Complications of Long-Term Home Total Parenteral Nutrition , 2004, Digestive Diseases and Sciences.

[66]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..